Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. - Wikidata - awgldk - TriplyDB

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.

http://www.wikidata.org/entity/Q33992270

about

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?What Do We Know about the Role of miRNAs in Pediatric Sarcoma?Functions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiation Antagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing's sarcoma to an inhibitor of glutamine metabolism Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group Systematic identification of genomic markers of drug sensitivity in cancer cells Gene Expression Music Algorithm-Based Characterization of the Ewing Sarcoma Stem Cell Signature An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.Mouse models for cancer stem cell research.Is There a Predisposition Gene for Ewing's Sarcoma?High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.Stem cells and bone diseases: new tools, new perspective Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development Animal models of soft-tissue sarcoma.Ewing sarcoma cells express RANKL and support osteoclastogenesis.EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.Generation and characterization of an immortalized human mesenchymal stromal cell line.Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition.Mesenchymal stem cell transformation and sarcoma genesis.Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence.Copy Number Alterations and Methylation in Ewing's Sarcoma.EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion.High-dose (111)in induces g1 cell cycle arrest and cell death in rat bone marrow mesenchymal stem cells.Promiscuous partnerships in Ewing's sarcoma.Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program.3D tissue-engineered model of Ewing's sarcoma Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507.

P2860

Q21198840-98B84EEF-B44E-48A0-87A5-41F58C8B0A7A Q24642797-B8E77693-CA30-44B0-9D1D-0750D7171EA9 Q26782649-D11489E1-040A-44E5-8850-0AF3ED75D8CC Q26800124-88889377-619C-4471-9296-54F745F462E7 Q26849397-445C1E65-AE0A-4BE0-A5F0-4E57E089231D Q27316754-817E1393-DE35-4876-86F1-23750CD80580 Q28076462-21E2D79D-2319-4423-AAFD-8A90FBEBA903 Q28541625-4D2660C4-C2D7-4CA6-9C54-492A1AC348DB Q29547695-AAEB97CD-BFC9-42D2-A6AA-5447B148485C Q30313976-D53C7870-2E51-49A9-AAFA-04630F3FD4E5 Q33275167-DF7B2DA3-8AEE-425C-8255-F5CD7F983B13 Q33559559-095ACB5E-6D71-40AD-9B68-6B0D4D0625A2 Q33638434-3B83E7CF-C0CB-486E-B29A-BE0FB589A6D7 Q33684472-9886D77B-28EA-4860-9664-C1738503EF0C Q33726883-CFD7D165-25A8-4560-B99D-ED745109D2D9 Q33750221-A2856CBB-7CDA-4A6D-AE53-02092E9E61F2 Q33798299-42502B9E-A459-41B2-AEF4-4AE496FA5495 Q33808340-F6B5B1D0-3F29-423B-B4C8-E1F44A8A5BC8 Q33861072-96318294-151B-4FE9-954A-8A9F822FF36C Q33925049-46C96022-56A9-4C1A-8AEB-B9D5E11EBF4C Q33997274-909AABEC-A544-4411-921B-A78ACEECBE80 Q34098113-219A5EA8-BA0E-435D-BA32-E637583AF26D Q34183161-86F02AFE-C54E-4B37-B65F-181D7EE114E1 Q34206278-457A5090-3CA2-4D14-A055-5C4B059F8BC9 Q34231344-E030A900-12A1-40CF-9E08-3D3047A4EB3E Q34263394-ADF6A800-6F74-49BC-BB03-47C112B9BF5F Q34283431-2D57EB1B-9FEB-4A60-93A7-D97D6F9A541D Q34518277-538056A3-91EC-4DB7-BE78-B91628526AE5 Q34654560-8BE41C39-0649-47FB-B379-ECB9B10D007B Q34666892-72474E75-5823-40A0-866D-A1549604508B Q34700651-6759B691-201C-4096-8970-3010B1352B57 Q34963463-145DC41C-3752-43C1-848A-D4F70F52A7AC Q35058617-27C3BBB8-CD56-4F65-A081-0D5B5CB0007D Q35131440-86A8FC73-ECC8-476C-85AD-FEED20125153 Q35181871-1481162B-7B1D-4CCA-99F7-9E30A63A89A6 Q35188770-395DF395-F9C2-4A85-9DE8-48B0B3132776 Q35194644-55E79DBA-B673-493B-9A61-F3E9D27518B5 Q35428655-4FC92357-A293-43AE-9280-B8462A883368 Q35459525-547E3296-9C6F-4B29-86D5-06AF7C6AA4C7 Q35627019-142AA67E-C806-47FC-9FB3-65C96F70F0E7

P2860

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.

http://www.wikidata.org/entity/Q33992270

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@ast

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@en

type

label

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@ast

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@en

prefLabel

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@ast

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@en

P1433

Q33992270-E3272D0C-1ADC-40DB-9098-B36B7E6CB1E5

P1476

Q33992270-A432025A-470D-43E0-84C1-6114FC1DEFB1

P2093

Q33992270-1E6C8C63-85BB-49B0-8736-D3E13B478835

Q33992270-284C6DF9-048B-487A-AA88-FD783866F986

Q33992270-7ABB4834-CEBE-4733-AFFF-D3708A83D89E

Q33992270-87A7C53A-A305-4096-8235-DC40F69A01EC

Q33992270-92186BA5-C88F-4FC1-A93C-C1A35E824336

Q33992270-B8EC8D87-D05F-40CD-A876-E7F51F97C371

Q33992270-B99CB3E4-2B2C-4949-B82F-553F679BBE6D

Q33992270-D46F4A7C-DF8C-45B2-BF0A-B6C2891FF853

P304

Q33992270-9628F279-50C6-44A7-962E-04FE402ED04E

P31

Q33992270-4E34A8B4-BCCB-415C-AEBC-7364EA2DC871

P356

Q33992270-F7D935E9-718B-4DF3-B364-534E46469134

P407

Q33992270-CC76A2FC-3547-466F-BDC8-5917DC04A403

P433

Q33992270-E4D49CC8-71FB-44DE-BB3F-C3D6D7B806EE

P478

Q33992270-872578B2-A7D0-4101-B009-52B5722C8E1C

P50

Q33992270-443CAE3C-5379-4F4B-9435-1EA9B30A2E2E

P577

Q33992270-151A3300-1F20-40B4-B0D2-D8F9539B0A62

P5875

Q33992270-ECE091BC-7497-4B07-A27E-CF86C0676B2A

P698

Q33992270-599821F3-2451-4102-B585-86416CE0970B

P356

0008-5472.CAN-05-1696

P1433

Cancer Research

P1476

Development of Ewing's sarcoma ...... mesenchymal progenitor cells.

@en

P2093

Carlos Garcia-Echeverria

http://www.w3.org/2001/XMLSchema#string

Francesco Hoffmann

http://www.w3.org/2001/XMLSchema#string

Ivan Stamenkovic

http://www.w3.org/2001/XMLSchema#string

Konstantinos Kaloulis

http://www.w3.org/2001/XMLSchema#string

Luisa Cironi

http://www.w3.org/2001/XMLSchema#string

Mario-Luca Suvà

http://www.w3.org/2001/XMLSchema#string

Nicolò Riggi

http://www.w3.org/2001/XMLSchema#string

Paolo Provero

http://www.w3.org/2001/XMLSchema#string

P304

11459-11468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-1696

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7413358

http://www.w3.org/2001/XMLSchema#string

P698

16357154

http://www.w3.org/2001/XMLSchema#string